VISX gets review of Nidek's ITC (International Trade Commission) victory:
This article was originally published in Clinica
Executive Summary
VISX, the laser refractive surgery manufacturer and licensor fighting to keep exclusivity on its US patents, has won a review of portions of the unfavourable decision handed down by the International Trade Commission (ITC) in December. The administrative law judge made a ruling that Japanese rival manufacturer Nidek did not infringe VISX's '418 patent. The case is due to be heard on March 6, though further appeals are likely, whatever the outcome.